LWMI
CLBT icon

Legacy Wealth Management (Idaho)’s Cellebrite CLBT Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21
Closed -$534 – 824
2024
Q4 		$534 Buy
+21
New +$404 ﹤0.01% 655

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s CLBT Position: Q1 2025 in Review

Legacy Wealth Management (Idaho) sold out of Cellebrite (CLBT) in Q1 2025, closing a stake of 21 shares — an estimated $534 sold.

Legacy Wealth Management (Idaho) first reported a position in CLBT in Q4 2024 and held it in 1 quarter. The position peaked at $534 in Q4 2024. 199 funds tracked by Wall St. Rank hold CLBT as of Q1 2025.

  • Legacy Wealth Management (Idaho) reported no remaining Cellebrite position as of Q1 2025 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 21 Cellebrite shares in Q1 2025, an estimated $534.
  • Legacy Wealth Management (Idaho) first reported a position in Cellebrite in Q4 2024 and held it in 1 quarter.
  • Legacy Wealth Management (Idaho)'s Cellebrite position peaked at $534 in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Cellebrite as of Q1 2025.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q1 2025, filed 16 May 2025.